Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia

被引：0
|
作者：
Gregory R. Mullen
Steven A. Kaplan
机构：
[1] Icahn School of Medicine at Mount Sinai,
来源：
Current Urology Reports | 2021年 / 22卷
关键词：
Urinary bladder; Overactive; Prostatic hyperplasia; Lower urinary tract symptoms; Mirabegron;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Efficacy and Safety of Flexible Dose Fesoterodine in Men and Women with Overactive Bladder Symptoms Including Nocturnal Urinary Urgency
    Weiss, Jeffrey P.
    Jumadilova, Zhanna
    Johnson, Theodore M., II
    FitzGerald, Mary P.
    Carlsson, Martin
    Martire, Diane L.
    Malhotra, Atul
    JOURNAL OF UROLOGY, 2013, 189 (04) : 1396 - 1401
  • [32] Seasonal Variation of Urinary Symptoms in Korean Men with Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
    Choi, Ho Chul
    Kwon, Jong Kyu
    Lee, Joo Yong
    Han, Jang Hee
    Jung, Hae Do
    Cho, Kang Su
    WORLD JOURNAL OF MENS HEALTH, 2015, 33 (02) : 81 - 87
  • [33] A drug safety evaluation of mirabegron in the management of overactive bladder
    Robinson, Dudley
    Thiagamoorthy, Ganesh
    Cardozo, Linda
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (05) : 689 - 696
  • [34] Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia
    Chapple, Christopher
    CURRENT OPINION IN UROLOGY, 2010, 20 (01) : 43 - 48
  • [35] The Efficacy and Safety of Combined Therapy with α-Blockers and Anticholinergics for Men with Benign Prostatic Hyperplasia: A Meta-Analysis
    Filson, Christopher P.
    Hollingsworth, John M.
    Clemens, J. Quentin
    Wei, John T.
    JOURNAL OF UROLOGY, 2013, 190 (06) : 2153 - 2160
  • [36] Efficacy and safety of Solifenacin combined with Mirabegron in treating overactive bladder in female patients following bladder instillation for bladder cancer
    Zhang, Lichao
    Chen, Yinghua
    Liao, Huasheng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2025, 17 (02): : 1144 - 1152
  • [37] Prostatic arterial embolisation for men with benign prostatic hyperplasia: a Cochrane review
    Jung, Jae Hung
    McCutcheon, Karen Ann
    Borofsky, Michael
    Young, Shamar
    Golzarian, Jafar
    Kim, Myung Ha
    Narayan, Vikram
    Dahm, Philipp
    BJU INTERNATIONAL, 2023, 131 (01) : 32 - 45
  • [38] Tadalafil for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
    Gonzalez, Ricardo R.
    Kaplan, Steven A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (04) : 609 - 617
  • [39] Safety and therapeutic efficacy of mirabegron 25 mg in older patients with overactive bladder and multiple comorbidities
    Lee, Yu Khun
    Kuo, Hann-Chorng
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (09) : 1330 - 1333
  • [40] Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo
    Chapple, Christopher R.
    Cruz, Francisco
    Cardozo, Linda
    Staskin, David
    Herschorn, Sender
    Choudhury, Nurul
    Stoelzel, Matthias
    Heesakkers, John
    Siddiqui, Emad
    EUROPEAN UROLOGY, 2020, 77 (01) : 119 - 128
12345